Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug;30(9-10):335-342.
doi: 10.1080/08958378.2018.1535634. Epub 2019 Jan 3.

Engineered nanoparticle exposure and cardiovascular effects: the role of a neuronal-regulated pathway

H Kan  1   2 , D Pan  1 , V Castranova  2
Affiliations
Review

Engineered nanoparticle exposure and cardiovascular effects: the role of a neuronal-regulated pathway

H Kan et al. Inhal Toxicol. 2018 Aug.

Abstract

Human and animal studies have confirmed that inhalation of particles from ambient air or occupational settings not only causes pathophysiological changes in the respiratory system, but causes cardiovascular effects as well. At an equal mass lung burden, nanoparticles are more potent in causing systemic microvascular dysfunction than fine particles of similar composition. Thus, accumulated evidence from animal studies has led to heightened concerns about the potential short- and long-term deleterious effects of inhalation of engineered nanoparticles on the cardiovascular system. This review highlights the new observations from animal studies, which document the adverse effects of pulmonary exposure to engineered nanoparticles on the cardiovascular system and elucidate the potential mechanisms involved in regulation of cardiovascular function, in particular, how the neuronal system plays a role and reacts to pulmonary nanoparticle exposure based on both in vivo and in vitro studies. In addition, this review also discusses the possible influence of altered autonomic nervous activity on preexisting cardiovascular conditions. Whether engineered nanoparticle exposure serves as a risk factor in the development of cardiovascular diseases warrants further investigation.

Keywords: Autonomic activity; Cardiovascular diseases; Engineered nanoparticles; Occupation exposure.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Densitometry values of phosphorylated cardiac troponin I (cTnI) from cardiac myocytes (CM) directly exposed to UFTiO2 and cardiac tissue (CT) obtained from the rat following pulmonary exposure to UFTiO2.
Figure 2.
Figure 2.
Fluorescence photomicrographs of substance P immunoreactivity in nodose ganglia.
Figure 3.
Figure 3.
The dose–response curve of mean blood pressure (MBP) in response to norepinephrine (NE) in the presence and absence of ruthenium red (RR) after exposure to UFTiO2.
Figure 4.
Figure 4.
The effect of ruthenium red (RR) on diastolic function of the heart after exposure to UFTiO2
Figure 5.
Figure 5.
Effects of multi-walled carbon nanotubes (MWCNTs) on the heart rate variability (HRV). Bar graph depicting % change of root mean square of successive differences (RMSSD), low frequency (LF) and high frequency (HF) from the basal level before exposure.
See this image and copyright information in PMC

References

    1. Ahmad S, Otaal PS, Rai TS, Bahl A, Saikia UN, Manoj RK, Thungapathra M, Talwar KK and Khullar M (2009). “Circulating proinflammatory cytokines and N-terminal pro-brain natriuretic peptide significantly decrease with recovery of left ventricular function in patients with dilated cardiomyopathy.” Mol Cell Biochem 324(1–2): 139–145. - PubMed
    1. Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, Navab M, Harkema J, Sioutas C, Lusis AJ and Nel AE (2008). “Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.” Circ Res 102(5): 589–596. - PMC - PubMed
    1. Bar H, Yacoby I and Benhar I (2008). “Killing cancer cells by targeted drug-carrying phage nanomedicines.” BMC Biotechnol 8: 37. - PMC - PubMed
    1. Bengalli R, Gualtieri M, Capasso L, Urani C and Camatini M (2017). “Impact of zinc oxide nanoparticles on an in vitro model of the human air-blood barrier.” Toxicol Lett 279: 22–32. - PubMed
    1. Bunger M (2007). “Strategies for developing and commercializing nanobio drugs, diagnostics and devices.” Nanomedicine (Lond) 2(2): 137–141. - PubMed

MeSH terms

Substances

LinkOut - more resources